Stefano Tomassi

Via Del Casale Di San Pio V, 44
Rome, 00165, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Development of High-Affinity CHD1 Chromodomain Inhibitors.

Development of High-Affinity CHD1 Chromodomain Inhibitors.

Journal: Journal of medicinal chemistry

Published: May 05, 2026

β-Cyclodextrin Inclusion Complexes with Model Pentapeptides: Role of the Tyrosine Position within the Peptide Chain.

β-Cyclodextrin Inclusion Complexes with Model Pentapeptides: Role of the Tyrosine Position within the Peptide Chain.

Journal: ChemistryOpen

Published: May 08, 2025

Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands.

Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands.

Journal: Journal of medicinal chemistry

Published: February 05, 2025

Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification.

Comprehensive structural investigation of a potent and selective CXCR4 antagonist via crosslink modification.

Journal: European journal of medicinal chemistry

Published: July 21, 2024

Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer.

Discovery of N-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer.

Journal: RSC medicinal chemistry

Published: July 17, 2024

Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites.

Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites.

Journal: European journal of medicinal chemistry

Published: May 20, 2024

Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity.

Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity.

Journal: Journal of medicinal chemistry

Published: January 22, 2024

A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitors.

A combined approach of structure-based virtual screening and NMR to interrupt the PD-1/PD-L1 axis: Biphenyl-benzimidazole containing compounds as novel PD-L1 inhibitors.

Journal: Archiv der Pharmazie

Published: October 10, 2023

Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumors.

Paper-based electrochemical device for early detection of integrin αvβ6 expressing tumors.

Journal: Communications chemistry

Published: July 10, 2023

First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.

First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8.

Journal: Journal of medicinal chemistry

Published: May 08, 2023

Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS).

Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS).

Journal: Ultrasonics sonochemistry

Published: December 21, 2022

Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells.

Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells.

Journal: European journal of medicinal chemistry

Published: September 19, 2022

Showing 1-12 of 46

Last Updated: 09/26/2026